These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


70 related items for PubMed ID: 8438484

  • 1. Potent CD8+ CTLs detected in anti-CD4 (OKT4A) MAb immunosuppressed cynomolgus recipients with prolonged allograft survival.
    Wee S, Kawai T, Knowles R, Colvin R, Cosimi AB.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):794-5. PubMed ID: 8438484
    [No Abstract] [Full Text] [Related]

  • 2. Immunosuppression of cynomolgus renal allograft recipients with humanized OKT4A monoclonal antibodies.
    Delmonico FL, Knowles RW, Colvin RB, Cavender DE, Kawai T, Bedle M, Stroka D, Preffer FI, Haug C, Cosimi AB.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):784-5. PubMed ID: 8438479
    [No Abstract] [Full Text] [Related]

  • 3. Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody.
    Cosimi AB, Delmonico FL, Wright JK, Wee SL, Preffer FI, Jolliffe LK, Colvin RB.
    Surgery; 1990 Aug; 108(2):406-13; discussion 413-4. PubMed ID: 2382234
    [Abstract] [Full Text] [Related]

  • 4. Treatment of rhesus monkey allograft recipients with a combination of anti-T-cell monoclonal antibodies.
    Rebellato L, Gross U, Carver M, Cunningham P, Riley R, Ross W, Knowles R, Thomas J.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):598-9. PubMed ID: 8094911
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunologic characterization of murine cardiac allograft recipients with long-term graft survival due to anti-VCAM-1 or anti-CD4 monoclonal antibody therapy.
    Orosz CG, Bergese SD, Huang EH, Vanbuskirk AM.
    Transplant Proc; 1995 Feb; 27(1):387-8. PubMed ID: 7533414
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients.
    Onodera K, Lehmann M, Akalin E, Volk HD, Sayegh MH, Kupiec-Weglinski JW.
    J Immunol; 1996 Sep 01; 157(5):1944-50. PubMed ID: 8757313
    [Abstract] [Full Text] [Related]

  • 9. Combined CTLA4Ig and anti-CD4/DC8 monoclonal antibody treatment prolongs survival of rat-to-mouse heterotopic cardiac xenografts.
    Rehman A, Tu Y, Flye MW.
    Transplant Proc; 1996 Apr 01; 28(2):660-1. PubMed ID: 8623331
    [No Abstract] [Full Text] [Related]

  • 10. CD4 and CD8 monoclonal antibody therapy in the dog: strategies to induce tolerance to renal allografts.
    Watson CJ, Davies HF, Cobbold SP, Rasmussen A, Rebello PR, Thiru S, Waldmann H, Calne RY, Metcalfe SM.
    Transplant Proc; 1995 Feb 01; 27(1):123-4. PubMed ID: 7878859
    [No Abstract] [Full Text] [Related]

  • 11. Devising murine models to better adapt clinical protocols: sequential low-dose treatment with anti-CD3 and anti-CD4 monoclonal antibodies to prevent fully mismatched allograft rejection.
    Campos HH, Bach JF, Chatenoud L.
    Transplant Proc; 1993 Feb 01; 25(1 Pt 1):798-9. PubMed ID: 8438486
    [No Abstract] [Full Text] [Related]

  • 12. Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments.
    Chen Z, Cobbold S, Waldmann H, Metcalfe S.
    Transplant Proc; 1993 Feb 01; 25(1 Pt 1):790-1. PubMed ID: 8438482
    [No Abstract] [Full Text] [Related]

  • 13. CD4 monoclonal antibodies in the preclinical dog renal allograft model.
    Watson CJ, Davies HS, Metcalfe SM, Cobbold SP, Rebello PR, Collier DS, Waldmann H, Calne RY.
    Transplant Proc; 1993 Feb 01; 25(1 Pt 1):804-6. PubMed ID: 8438491
    [No Abstract] [Full Text] [Related]

  • 14. Anti-CD4 mAb therapy significantly delays the alloantibody response in a cynomolgus renal transplant model.
    Wee S, Stroka DM, D'Souza G, Fuller TC, Fitzpatrick DM, Cosimi AB.
    Transplantation; 1994 Jul 27; 58(2):261-4. PubMed ID: 7913778
    [No Abstract] [Full Text] [Related]

  • 15. OKT4A monoclonal antibody immunosuppression of cynomolgus renal allograft recipients.
    Cosimi AB, Delmonico FL, Wright JK, Wee SL, Preffer FI, Bedle M, Colvin RB.
    Transplant Proc; 1991 Feb 27; 23(1 Pt 1):501-3. PubMed ID: 1990600
    [No Abstract] [Full Text] [Related]

  • 16. Effect of monoclonal antibody on corneal graft survival across major and minor histocompatibility mismatches.
    Duguid IG, Koulmanda M, Mandel TE.
    Transplant Proc; 1993 Feb 27; 25(1 Pt 1):844. PubMed ID: 8438499
    [No Abstract] [Full Text] [Related]

  • 17. Treatment with humanized monoclonal antibodies against CD80 and CD86 combined with sirolimus prolongs renal allograft survival in cynomolgus monkeys.
    Bîrsan T, Hausen B, Higgins JP, Hubble RW, Klupp J, Stalder M, Celniker A, Friedrich S, O'Hara RM, Morris RE.
    Transplantation; 2003 Jun 27; 75(12):2106-13. PubMed ID: 12829920
    [Abstract] [Full Text] [Related]

  • 18. The effects of OKT4A monoclonal antibody on cellular immunity of nonhuman primate renal allograft recipients.
    Wee SL, Stroka DM, Preffer FI, Jolliffe LK, Colvin RB, Cosimi AB.
    Transplantation; 1992 Mar 27; 53(3):501-7. PubMed ID: 1532265
    [Abstract] [Full Text] [Related]

  • 19. Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8.
    Chen Z, Cobbold S, Metcalfe S, Waldmann H.
    Eur J Immunol; 1992 Mar 27; 22(3):805-10. PubMed ID: 1547823
    [Abstract] [Full Text] [Related]

  • 20. Use of OKT4A (a murine monoclonal anti-CD4 antibody) in human organ transplantation: initial clinical experience.
    Norman DJ, Bennett WM, Cobanoglu A, Hershberger R, Hosenpud JD, Meyer MM, Misiti J, Ott G, Ratkovec R, Shihab F.
    Transplant Proc; 1993 Feb 27; 25(1 Pt 1):802-3. PubMed ID: 8438490
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.